High Flow Nasal Therapy for COPD

This trial examines the effectiveness of a device called myAirvo 3, a high-flow nasal therapy device, for individuals with moderate to very severe COPD, a lung condition that makes breathing difficult. Participants will either use this device alongside their usual COPD care or continue with their regular care. The researchers aim to determine if myAirvo 3 can reduce serious flare-ups that often require hospital visits. Suitable candidates have experienced COPD flare-ups needing hospitalization in the last six weeks and are willing to use the device daily at home. As an unphased trial, this study provides a unique opportunity to enhance understanding of how myAirvo 3 can improve COPD management.

The trial does not specify if you need to stop taking your current medications. It seems you can continue your usual COPD medical care while participating.

Research has shown that the myAirvo 3 device, used for High Flow Nasal Therapy (HFNT), is generally safe for people with long-term breathing problems. This device delivers warm and moist air or oxygen through a special nasal tube. Studies have found that individuals with chronic breathing issues tolerate this therapy well at home. No major reports of serious side effects have emerged. However, like any medical treatment, some individuals might experience mild discomfort or irritation from the nasal tube. Overall, evidence suggests that myAirvo 3 is a safe choice for patients with moderate to very severe COPD.¹²³⁴⁵

Researchers are excited about myAirvo 3 for COPD because it offers a unique approach with its integrated humidifier and flow generator. Unlike standard treatments that might focus on medications or inhalers, myAirvo 3 delivers high-flow oxygen therapy directly through a nasal cannula, which can provide consistent, comfortable respiratory support. This method may improve patient outcomes by enhancing oxygen delivery and maintaining airway humidity, potentially leading to better management of symptoms and improved quality of life for those with COPD.

Studies have shown that High Flow Nasal Therapy (HFNT) using the myAirvo 3 device can help people with COPD breathe more easily. In this trial, one group of participants will receive usual COPD care with the myAirvo 3 integrated humidifier and flow generator. Research suggests that using this device at home might lower the risk of hospital readmission for COPD symptoms. Patients using HFNT have reported better breathing and increased comfort. The myAirvo 3 delivers warm, moist air, which can reduce lung strain. Early findings also suggest it may help clear mucus more effectively than regular treatments. Overall, the myAirvo 3 shows promise in improving the quality of life for those with severe COPD.¹²⁵⁶⁷